Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.74 EUR
−7.03 M EUR
2.94 M EUR
6.13 M
About ADVICENNE
Sector
CEO
Didier Laurens
Headquarters
Paris
Website
Founded
2007
ISIN
FR0013296746
FIGI
BBG00PGGB9H1
Advicenne SA is a pharmaceutical company, which engages in the development of innovative treatments in Nephrology. It develops treatment for both adults and kids. The company was founded in 2007 by Luc-André Granier and Caroline Roussel-Maupetit and is headquartered in Paris, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 3MM is 2.02 EUR — it has increased by 11.45% in the past 24 hours. Watch ADVICENNE SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ADVICENNE SA stocks are traded under the ticker 3MM.
3MM stock has risen by 20.95% compared to the previous week, the month change is a −2.89% fall, over the last year ADVICENNE SA has showed a −14.80% decrease.
We've gathered analysts' opinions on ADVICENNE SA future price: according to them, 3MM price has a max estimate of 4.00 EUR and a min estimate of 4.00 EUR. Watch 3MM chart and read a more detailed ADVICENNE SA stock forecast: see what analysts think of ADVICENNE SA and suggest that you do with its stocks.
3MM stock is 12.56% volatile and has beta coefficient of −0.42. Track ADVICENNE SA stock price on the chart and check out the list of the most volatile stocks — is ADVICENNE SA there?
Today ADVICENNE SA has the market capitalization of 24.44 M, it has increased by 7.72% over the last week.
Yes, you can track ADVICENNE SA financials in yearly and quarterly reports right on TradingView.
ADVICENNE SA is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ADVICENNE SA revenue for the last half-year amounts to 1.91 M EUR, despite the estimated figure of 2.42 M EUR. In the next half-year revenue is expected to reach 2.00 M EUR.
3MM net income for the last half-year is −5.53 M EUR, while the previous report showed −3.30 M EUR of net income which accounts for −67.82% change. Track more ADVICENNE SA financial stats to get the full picture.
No, 3MM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 20.00 employees. See our rating of the largest employees — is ADVICENNE SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADVICENNE SA EBITDA is −7.10 M EUR, and current EBITDA margin is −230.46%. See more stats in ADVICENNE SA financial statements.
Like other stocks, 3MM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADVICENNE SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADVICENNE SA technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADVICENNE SA stock shows the buy signal. See more of ADVICENNE SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.